Pharmacogenetics of VKORC1 in warfarin resistant patients.
Warfarin is a commonly prescribed anticoagulant that displays wide inter-individual variability in treatment response and dosage. It acts by inhibiting the vitamin K epoxide reductase (VKOR) enzyme in the liver. Genetic variations in vitamin K epoxide reductase complex subunit 1(VKORC1), have been a...
Saved in:
Main Author: | Ong, Jacqueline Kai Mei. |
---|---|
Other Authors: | Balram Chowbay |
Format: | Final Year Project |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/41759 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: Transthyretin precursor as a potential biomarker
by: Saminathan R., et al.
Published: (2019) -
Dissection of mechanistic action of anticancer multidrug resistance reversal agents from a natural product library.
by: Ong, Yi Jun.
Published: (2010) -
Transcriptional variation in human malaria parasites and its association with drug resistance
by: Mok, Sachel
Published: (2013) -
Characterizing drug resistance in hypoxia-adapted chronic myeloid leukaemia cells.
by: Muhammad Rauzan Rafman.
Published: (2013) -
Antimicrobial resistance of Salmonella enterica and Escherichia coli in various meat samples in Ghana
by: Sultan, Stella Amelia
Published: (2018)